Jiangsu Sihuan Bioengineering Co Ltd banner
J

Jiangsu Sihuan Bioengineering Co Ltd
SZSE:000518

Watchlist Manager
Jiangsu Sihuan Bioengineering Co Ltd
SZSE:000518
Watchlist
Price: 2.94 CNY -1.67% Market Closed
Market Cap: ¥3B

Balance Sheet

Balance Sheet Decomposition
Jiangsu Sihuan Bioengineering Co Ltd

Balance Sheet
Jiangsu Sihuan Bioengineering Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
298
352
395
388
306
194
75
65
71
135
201
196
140
35
24
65
41
39
53
55
38
28
15
8
Cash
0
0
0
0
0
0
0
0
0
0
0
1
0
1
0
5
0
0
0
0
38
28
15
8
Cash Equivalents
298
352
395
388
306
194
75
65
71
135
201
195
139
34
24
60
41
39
53
54
0
0
0
0
Short-Term Investments
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Receivables
136
112
150
254
240
248
259
146
93
91
196
152
89
123
177
142
141
139
141
157
142
119
77
74
Accounts Receivables
72
87
101
129
157
160
152
85
79
84
82
94
73
84
99
117
112
130
127
145
136
106
73
66
Other Receivables
64
26
49
125
83
88
107
61
14
8
114
58
16
39
78
25
29
10
14
12
6
14
4
8
Inventory
193
185
165
154
117
180
143
59
191
42
43
33
48
42
212
462
584
581
557
449
431
409
409
360
Other Current Assets
70
24
25
49
71
43
5
146
54
88
66
76
173
148
30
7
4
4
5
8
9
9
9
4
Total Current Assets
697
674
736
845
734
665
481
416
410
356
506
456
450
349
443
676
770
763
756
669
620
565
509
447
PP&E Net
232
295
321
340
433
420
317
269
267
251
247
250
237
330
304
245
85
90
81
85
92
85
84
75
PP&E Gross
232
295
321
340
433
420
317
269
267
251
247
250
237
330
304
245
85
90
81
85
92
85
84
75
Accumulated Depreciation
29
29
45
60
71
101
77
93
105
111
49
65
79
92
104
120
81
87
99
102
108
121
134
144
Intangible Assets
150
163
161
149
80
88
52
43
27
169
172
162
98
102
59
69
46
40
50
44
41
47
30
11
Goodwill
0
0
0
0
0
49
12
0
0
0
6
6
0
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
3
13
12
18
15
8
20
48
46
182
27
26
26
25
24
23
22
23
22
21
39
36
33
29
Other Long-Term Assets
0
0
0
38
34
0
0
0
4
4
11
12
12
13
5
4
9
10
7
5
6
5
5
5
Other Assets
0
0
0
0
0
49
12
0
0
0
6
6
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
1 082
N/A
1 145
+6%
1 230
+7%
1 389
+13%
1 296
-7%
1 229
-5%
883
-28%
776
-12%
753
-3%
962
+28%
970
+1%
913
-6%
823
-10%
818
-1%
835
+2%
1 017
+22%
932
-8%
926
-1%
916
-1%
824
-10%
799
-3%
738
-8%
661
-10%
567
-14%
Liabilities
Accounts Payable
16
22
26
27
22
25
11
8
14
13
13
17
15
26
84
313
19
61
63
58
61
53
50
61
Accrued Liabilities
35
33
28
47
37
32
19
8
9
11
10
13
10
8
9
12
8
9
10
10
12
15
13
13
Short-Term Debt
3
3
52
192
212
132
2
52
2
0
0
0
0
0
35
53
50
70
16
16
16
16
16
13
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
10
2
0
0
0
0
0
0
4
4
5
6
Other Current Liabilities
44
24
28
16
21
28
16
13
15
57
29
49
52
56
81
27
177
143
164
54
28
28
33
42
Total Current Liabilities
99
82
134
282
292
217
48
81
40
82
52
79
85
92
209
405
254
283
254
138
121
116
118
134
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
31
28
26
21
Minority Interest
3
4
4
4
3
6
5
4
0
163
205
84
56
41
2
0
47
44
47
44
41
36
31
27
Other Liabilities
0
0
0
0
0
0
2
3
0
1
2
3
5
5
17
1
2
0
2
1
1
0
4
14
Total Liabilities
102
N/A
86
-16%
138
+61%
286
+107%
296
+3%
224
-24%
54
-76%
87
+60%
40
-54%
246
+509%
260
+6%
167
-36%
148
-12%
137
-7%
228
+66%
406
+78%
303
-25%
327
+8%
302
-7%
183
-39%
193
+6%
181
-6%
179
-1%
196
+9%
Equity
Common Stock
179
515
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
Retained Earnings
72
139
60
71
33
25
202
341
318
314
320
310
381
375
449
445
437
467
453
425
460
509
584
694
Additional Paid In Capital
729
405
3
3
3
1
1
1
1
1
1
26
26
25
25
25
36
36
36
36
36
36
36
36
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
Total Equity
980
N/A
1 059
+8%
1 092
+3%
1 103
+1%
1 000
-9%
1 006
+1%
829
-18%
689
-17%
712
+3%
716
+1%
710
-1%
746
+5%
675
-9%
681
+1%
607
-11%
611
+1%
629
+3%
599
-5%
614
+2%
641
+4%
606
-5%
557
-8%
482
-14%
372
-23%
Total Liabilities & Equity
1 082
N/A
1 145
+6%
1 230
+7%
1 389
+13%
1 296
-7%
1 229
-5%
883
-28%
776
-12%
753
-3%
962
+28%
970
+1%
913
-6%
823
-10%
818
-1%
835
+2%
1 017
+22%
932
-8%
926
-1%
916
-1%
824
-10%
799
-3%
738
-8%
661
-10%
567
-14%
Shares Outstanding
Common Shares Outstanding
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
1 030
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett